Literature DB >> 16585136

N-Glycosylation of the MUC1 mucin in epithelial cells and secretions.

Simon Parry1, Franz Georg Hanisch, Shih-Hsing Leir, Mark Sutton-Smith, Howard R Morris, Anne Dell, Ann Harris.   

Abstract

The MUC1 mucin is an important tumor-associated antigen that shows extensive glycosylation in vivo. The O-glycosylation of this molecule, which has been well characterized in many cell types and tissues, is important in conferring the unusual biochemical and biophysical properties on a mucin. N-Glycosylation is crucial to the folding, sorting, membrane trafficking, and secretion of many proteins. Here, we evaluated the N-glycosylation of MUC1 derived from two sources: endogenous MUC1 isolated from human milk and a recombinant epitope-tagged MUC1F overexpressed in Caco2 colon carcinoma cells. N-Glycans on purified MUC1F/MUC1 were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS), gas chromatography-mass spectrometry (GC-MS), and CAD-ESI-MS/MS. The spectra indicate that MUC1F N-glycans have compositions consistent with high-mannose structures (Hex(5-9)HexNAc(2)) and complex/hybrid-type glycans (NeuAc(0-3)Fuc(0-3)Hex(3-8)HexNAc(3-7)). Many of the N-glycan structures are identical on MUC1F and native MUC1; however, a marked difference is seen between the N-glycans on membrane-bound and secreted forms of the native molecule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585136     DOI: 10.1093/glycob/cwj110

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  32 in total

Review 1.  Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.

Authors:  Seema Chugh; Vinayaga S Gnanapragassam; Maneesh Jain; Satyanarayana Rachagani; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Biochim Biophys Acta       Date:  2015-08-28

Review 2.  Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.

Authors:  Donella M Beckwith; Maré Cudic
Journal:  Semin Immunol       Date:  2020-01-09       Impact factor: 11.130

Review 3.  MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad.

Authors:  Lacey Haddon; Judith Hugh
Journal:  Clin Exp Metastasis       Date:  2015-03-11       Impact factor: 5.150

4.  Transmembrane mucins as novel therapeutic targets.

Authors:  Pamela E Constantinou; Brian P Danysh; Neeraja Dharmaraj; Daniel D Carson
Journal:  Expert Rev Endocrinol Metab       Date:  2011-11

5.  Enterocyte glycosylation is responsive to changes in extracellular conditions: implications for membrane functions.

Authors:  Dayoung Park; Gege Xu; Mariana Barboza; Ishita M Shah; Maurice Wong; Helen Raybould; David A Mills; Carlito B Lebrilla
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

Review 6.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 7.  Glycomics and glycoproteomics of membrane proteins and cell-surface receptors: Present trends and future opportunities.

Authors:  Kevin Brown Chandler; Catherine E Costello
Journal:  Electrophoresis       Date:  2016-03-29       Impact factor: 3.535

8.  MUC1 is a substrate for gamma-secretase.

Authors:  Joanne Julian; Neeraja Dharmaraj; Daniel D Carson
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

9.  Glycomic mapping of O- and N-linked glycans from major rat sublingual mucin.

Authors:  Shin-Yi Yu; Kay-Hooi Khoo; Zhangung Yang; Anthony Herp; Albert M Wu
Journal:  Glycoconj J       Date:  2007-09-22       Impact factor: 2.916

10.  The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays.

Authors:  Tingting Yue; Irwin J Goldstein; Michael A Hollingsworth; Karen Kaul; Randall E Brand; Brian B Haab
Journal:  Mol Cell Proteomics       Date:  2009-04-17       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.